首页> 美国卫生研究院文献>Cancers >Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors
【2h】

Validation of the 8th Edition American Joint Commission on Cancer (AJCC) Gallbladder Cancer Staging System: Prognostic Discrimination and Identification of Key Predictive Factors

机译:验证第8版美国癌症(AJCC)胆囊癌癌症分期系统:预后辨别和关键预测因素的识别

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Despite implementing numerous changes in the American Joint Committee on Cancer (AJCC) staging system for gallbladder cancer (GBC), the ability to accurately prognosticate survival in these patients has not been vigorously evaluated. The purpose of our study was to compare the prognostic ability of AJCC 7th and 8th edition, investigate the effect of AJCC 8th edition nodal status on the survival, and identify risk factors associated with the survival after N reclassification in GBC patients. We used the largest cancer database in the United States and determined that the updated AJCC 8th edition GBC staging system was comparable to the 7th edition, with no major improvements in survival discrimination. The recently implemented changes in N classification do not appear to improve the prognostic performance of the AJCC cancer staging system with regard to survival in GBC patients.
机译:尽管在胆囊癌(GBC)癌症(AJCC)癌症系统(AJCC)分期系统(GBC)中实施了众多变化,但在这些患者中准确预后存活的能力尚未得到大力评估。我们研究的目的是比较AJCC 7和第8版的预后能力,调查AJCC第8版节点状况对生存期的影响,并确定GBC患者N重新分类后的存活危险因素。我们在美国使用最大的癌症数据库,并确定了更新的AJCC第8版GBC分期系统与第7版相当,生存歧视无重大改进。最近实施的N分类的变化似乎没有提高AJCC癌症分期系统关于GBC患者的存活的预后性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号